217 related articles for article (PubMed ID: 34280501)
1. Bursal peptide BP-IV as a novel immunoadjuvant enhances the protective efficacy of an epitope peptide vaccine containing T and B cell epitopes of the H9N2 avian influenza virus.
Liu Y; Shen T; Zhou J; Chen L; Shi S; Wang X; Zhang M; Wang C; Liao C
Microb Pathog; 2021 Sep; 158():105095. PubMed ID: 34280501
[TBL] [Abstract][Full Text] [Related]
2. Development of PDA Nanoparticles for H9N2 Avian Influenza BPP-V/BP-IV Epitope Peptide Vaccines: Immunogenicity and Delivery Efficiency Improvement.
Liu Y; Wang X; Zhou J; Shi S; Shen T; Chen L; Zhang M; Liao C; Wang C
Front Immunol; 2021; 12():693972. PubMed ID: 34386005
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant Activity of Bursal Pentapeptide-(III-V) in Mice Immunized with the H9N2 Avian Influenza Vaccine.
Zhou J; Zhang C; Liu Z; Liu Y; Cai K; Shen T; Liao C; Wang C
Protein Pept Lett; 2018; 25(8):757-766. PubMed ID: 30081784
[TBL] [Abstract][Full Text] [Related]
4. Comparison of immunoadjuvant activities of four bursal peptides combined with H9N2 avian influenza virus vaccine.
Zhang C; Zhou J; Liu Z; Liu Y; Cai K; Shen T; Liao C; Wang C
J Vet Sci; 2018 Nov; 19(6):817-826. PubMed ID: 30173497
[TBL] [Abstract][Full Text] [Related]
5. Bursopentine as a novel immunoadjuvant enhances both humoral and cell-mediated immune responses to inactivated H9N2 Avian Influenza virus in chickens.
Li D; Xue M; Wang C; Wang J; Chen P
Clin Vaccine Immunol; 2011 Sep; 18(9):1497-502. PubMed ID: 21795462
[TBL] [Abstract][Full Text] [Related]
6. The Inducing Roles of the New Isolated Bursal Hexapeptide and Pentapeptide on the Immune Response of AIV Vaccine in Mice.
Hao SS; Zong MM; Zhang Z; Cai JX; Zheng Y; Feng XL; Wang C
Protein Pept Lett; 2019; 26(7):542-549. PubMed ID: 30950342
[TBL] [Abstract][Full Text] [Related]
7. Development of an Inactivated H7N9 Subtype Avian Influenza Serological DIVA Vaccine Using the Chimeric HA Epitope Approach.
Sun Z; Wang Q; Li G; Li J; Chen S; Qin T; Ma H; Peng D; Liu X
Microbiol Spectr; 2021 Oct; 9(2):e0068721. PubMed ID: 34585985
[TBL] [Abstract][Full Text] [Related]
8. Gene cloning, expression and immune adjuvant properties of the recombinant fusion peptide Tα1-BLP on avian influenza inactivate virus vaccine.
Zhang C; Zhou J; Cai K; Zhang W; Liao C; Wang C
Microb Pathog; 2018 Jul; 120():147-154. PubMed ID: 29730515
[TBL] [Abstract][Full Text] [Related]
9. Bursin-like peptide (BLP) enhances H9N2 influenza vaccine induced humoral and cell mediated immune responses.
Wang C; Li X; Wu T; Li D; Niu M; Wang Y; Zhang C; Cheng X; Chen P
Cell Immunol; 2014; 292(1-2):57-64. PubMed ID: 25282449
[TBL] [Abstract][Full Text] [Related]
10. In ovo administration of retinoic acid enhances cell-mediated immune responses against an inactivated H9N2 avian influenza virus vaccine.
Alizadeh M; Raj S; Shojadoost B; Matsuyama-Kato A; Boodhoo N; Abdelaziz K; Sharif S
Vaccine; 2023 Nov; 41(48):7281-7289. PubMed ID: 37923694
[TBL] [Abstract][Full Text] [Related]
11. Chimeric Newcastle Disease Virus-like Particles Containing DC-Binding Peptide-Fused Haemagglutinin Protect Chickens from Virulent Newcastle Disease Virus and H9N2 Avian Influenza Virus Challenge.
Xu X; Qian J; Qin L; Li J; Xue C; Ding J; Wang W; Ding W; Yin R; Jin N; Ding Z
Virol Sin; 2020 Aug; 35(4):455-467. PubMed ID: 32274680
[TBL] [Abstract][Full Text] [Related]
12. B cell epitopes in the intrinsically disordered regions of neuraminidase and hemagglutinin proteins of H5N1 and H9N2 avian influenza viruses for peptide-based vaccine development.
Ramamurthy M; Sankar S; Abraham AM; Nandagopal B; Sridharan G
J Cell Biochem; 2019 Oct; 120(10):17534-17544. PubMed ID: 31111560
[TBL] [Abstract][Full Text] [Related]
13. Enhancing immunogenicity and protective efficacy of inactivated avian influenza H9N2vaccine with recombinant chicken IFN-α in chicken.
Gan L; Tian Y; Zhao Y; Shan XQ; Zhou W; Xia BB; Chen J; Wang ML; Zhao J
Vet Microbiol; 2019 Jul; 234():77-82. PubMed ID: 31213275
[TBL] [Abstract][Full Text] [Related]
14. Quick and improved immune responses to inactivated H9N2 avian influenza vaccine by purified active fraction of Albizia julibrissin saponins.
Sun H; Fei L; Zhu B; Shi M
BMC Vet Res; 2020 Nov; 16(1):427. PubMed ID: 33160337
[TBL] [Abstract][Full Text] [Related]
15. Examination of the effects of virus inactivation methods on the induction of antibody- and cell-mediated immune responses against whole inactivated H9N2 avian influenza virus vaccines in chickens.
Astill J; Alkie T; Yitbarek A; Taha-Abdelaziz K; Bavananthasivam J; Nagy É; Petrik JJ; Sharif S
Vaccine; 2018 Jun; 36(27):3908-3916. PubMed ID: 29853199
[TBL] [Abstract][Full Text] [Related]
16. Delivery of an inactivated avian influenza virus vaccine adjuvanted with poly(D,L-lactic-co-glycolic acid) encapsulated CpG ODN induces protective immune responses in chickens.
Singh SM; Alkie TN; Nagy É; Kulkarni RR; Hodgins DC; Sharif S
Vaccine; 2016 Sep; 34(40):4807-13. PubMed ID: 27543454
[TBL] [Abstract][Full Text] [Related]
17. Conserved peptides enhance immune efficiency of inactive vaccines against emerging avian influenza viruses in chicken.
Xiao J; Zhang L; Wang Z; Xiang W; Lu P; Zhao Y; Han M; Ma A; Qi P; Wang M; Gao GF; Liu WJ
Sci China Life Sci; 2017 Dec; 60(12):1340-1347. PubMed ID: 29230639
[TBL] [Abstract][Full Text] [Related]
18. Systemic immune responses to an inactivated, whole H9N2 avian influenza virus vaccine using class B CpG oligonucleotides in chickens.
Singh SM; Alkie TN; Hodgins DC; Nagy É; Shojadoost B; Sharif S
Vaccine; 2015 Jul; 33(32):3947-52. PubMed ID: 26092309
[TBL] [Abstract][Full Text] [Related]
19. Vaccination with recombinant 4 × M2e.HSP70c fusion protein as a universal vaccine candidate enhances both humoral and cell-mediated immune responses and decreases viral shedding against experimental challenge of H9N2 influenza in chickens.
Dabaghian M; Latify AM; Tebianian M; Nili H; Ranjbar AR; Mirjalili A; Mohammadi M; Banihashemi R; Ebrahimi SM
Vet Microbiol; 2014 Nov; 174(1-2):116-26. PubMed ID: 25293397
[TBL] [Abstract][Full Text] [Related]
20. Antibody and T-cell responses to a virosomal adjuvanted H9N2 avian influenza vaccine: impact of distinct additional adjuvants.
Radosević K; Rodriguez A; Mintardjo R; Tax D; Bengtsson KL; Thompson C; Zambon M; Weverling GJ; Uytdehaag F; Goudsmit J
Vaccine; 2008 Jul; 26(29-30):3640-6. PubMed ID: 18514980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
